Anavex Life Sciences Corp. (OTCQX:AVXL) announced today that Christopher U. Missling, PhD, President and Chief Executive Officer, will be presenting at the 2015 Marcum Microcap Conference on Wednesday, May 27, 2015 at 3:30 p.m. ET in the Winter Garden Room at the Grand Hyatt in New York City.
The presentation is set to include an overview of the ongoing Phase 2a clinical trial of ANAVEX2-73 and ANAVEX PLUS that is being conducted by Anavex in Alzheimer’s patients. The company’s other products that are being developed will also be discussed as well.
Management from Anavex plans to be available for one-on-one meetings with members of the investment community at the conference. If you would like to schedule a meeting with management then contact Anavex at firstname.lastname@example.org.
The Marcum Microcap Conference will be held May 27th through the 28th in New York City. This event will bring together fund managers and high net worth investors that have a focus on small cap equities. There will be over 2,000 participants from all segments of the microcap market expected to participate at the conference.